The AZ HEROES research study is expanding its scope to assess vaccine effectiveness, as well as increasing eligibility to include college students.
The new test aims to combine the speed of existing nasal swab antigen tests with the high accuracy of nasal swab PCR, or polymerase chain reaction, tests.
The antibody test developed at the UArizona Health Sciences can be used to confirm a positive antibody response after receiving a COVID-19 vaccine.
AIDS women’s health award to Dr. Liz Connick; Liver Institute wins CDC designation; Dr. Julie Bauman co-chairs cancer prevention committee.
University of Arizona Health Sciences immunobiologist Dr. Deepta Bhattacharya says the COVID-19 vaccine is safe, and he will take it when it becomes available.
Antibody tests, groundbreaking research and community outreach are a few of the ways the University of Arizona Health Sciences met the test of a pandemic.
UArizona Health Sciences immunobiologists have created a five-module chimeric antigen receptor T cell that is showing early potential to fight Type 1 diabetes.
At 7,541 administered from Nov. 9-13, the university’s COVID-19 testing, which continues through Nov. 25, is succeeding in goal to test large numbers of students before they head home for holidays.
The university will expand in-person instruction with half the semester left to go, bringing about 1,500 more students to campus a week.
Researchers are expanding research showing that creating good sleeping habits can help people quit smoking to focus on smokers who are HIV positive.
The contribution will allow UArizona researchers to continue developing better, more efficient and effective tests for people across the state.
The university also will conduct a testing blitz prior to the Thanksgiving holiday in an effort to reduce travel-related spread of COVID-19.
A new diagnostic test for coronavirus relies on gargling with saltwater instead of using a nasal swab. Initial results have been encouraging, UArizona virology expert Dr. Michael Worobey says.